1. Introduction {#s0005}
===============

22q11.2 deletion syndrome (22q11.2DS) affects several organs including brain structure and function ([@bb0045]). It manifests as various neuropsychiatric symptoms such as cognitive dysfunction, autism spectrum disorder or attention deficit hyperactive disorder ([@bb0250]). 22q11.2DS represents one of the largest known genetic risk factors for schizophrenia. Lifetime prevalence of schizophrenia is approximately 25% in 22q11.2DS compared to approximately 1% in the general population ([@bb0225]). Identifying stable neurocognitive markers that contribute to understand and predict the psychiatric phenotype in 22q11.2DS is thus of high relevance for early schizophrenia prevention.

Social cognition dysfunction, and more specifically emotional face perception, was proposed as a robust endophenotype of schizophrenia ([@bb0135]; [@bb0245]). The underlying assumption is that misinterpretation of other\'s emotional state may participate in behaviors characterized by hostility, delusion, aggression, and social withdrawal. One key mechanism to understand others\' mental state is the ability to perceive and recognize facial expressions. Actually, a deficit in facial emotion processing is widely observed in children and young adults with 22q11.2DS ([@bb0015]; [@bb0065]; [@bb0165]; [@bb0185]; [@bb0220]). Surprisingly, only few studies reported that it might increase the risk of psychotic transition ([@bb0005]; [@bb0015]; [@bb0145], [@bb0150]; [@bb0310]) while more extensive data incriminated deficits in complex social cognitive processes (i.e., theory of mind and perspective taking) or executive functions ([@bb0005]; [@bb0145], [@bb0150]; [@bb0250]; [@bb0270]; [@bb0290]; [@bb0310]).

Hence, deeper investigations are needed to determine whether facial emotion processing could be a neurocognitive endophenotype of psychotic symptom in 22q11DS and rule out possible confounding explanations. The first issue concerns the specificity of emotional face perception measurement when using standard behavioural tasks. For instance, the widely used emotional face labelling tasks are unable to disentangle the contribution of automatic facial expression perception (i.e., visual processing of a change of facial expression) and explicit facial emotion recognition (i.e., emotion attribution to an expressive facial percept). Critically, behavioural measures can be contaminated by response-related unspecific processes such as decision-making or response inhibition ([@bb0010]; [@bb0165]). Second, classical group studies insufficiently control genetic or environmental stress variability that could mediate the incomplete penetrance for psychiatric phenotypes ([@bb0040]; [@bb0080]; [@bb0130]; [@bb0285]). It remains thus unclear whether neurocognitive markers identified in group studies can be used in clinical care, i.e., for individual participants.

To circumvent these limitations, the present study reports a case of monozygotic twins who are discordant for psychiatric symptoms. Twin studies are a valuable source of information on genotype-phenotype relationship. In the field of schizophrenia research, they recently raised several hypotheses on the etiology of psychotic symptoms, including post zygotic mutations ([@bb0070]), somatic mutations ([@bb0210]), or inflammatory processes ([@bb0050]). In 22q11.2DS, although previous twin studies in childhood reported discordance for heart defect ([@bb0115]; [@bb0140]), none has yet addressed psychiatric symptoms in adults. In the present study, twins with 22q11.2DS were submitted to a classical emotion recognition labelling task and a frequency-tagging approach in electroencephalography (EEG) to disentangle their ability to perceive a change of facial expression from the recognition of the emotion expressed. This EEG approach provides an implicit neural measurement of facial expression perception exempt from other unspecific processes and is adapted to single case designs with the significance of individual brain responses estimated in healthy participants in previous studies ([@bb0100]; [@bb0170]; ([@bb0180]; [@bb0215]; [@bb0230]). The present study thus represents a privileged opportunity to highlight reliable endophenotypes of psychiatric symptoms at an individual level since the participants share most genetic and environmental confounding factors and the measurement specifically quantifies perceptual response to expressive faces without being influenced by decision and labelling-related processes.

2. Materials and methods {#s0010}
========================

The study was carried out in accordance with the latest version of the Declaration of Helsinki. The experimental procedure was approved by the ethic committee CPP SUD-EST II (ANSM 151109B-31; ID RCB: 2015-A01247) and participants gave their written informed consent.

2.1. Participants {#s0015}
-----------------

Two male 22-year-old monozygotic twins with 22q11.2DS participated in the study. They were carefully selected because of the rare phenotypic discordance considering psychiatric manifestations. An experienced psychiatrist examined both twins according to DSM-5 criteria axis 1 and completed Positive And Negative Syndrome Scale (PANSS) for schizophrenia ([@bb0155]). Diagnosis of 22q11.2DS was confirmed by complete genomic hybridization (CHG-Array) and verified in both patients by fluorescent in situ hybridization (FISH) revealing an identical heterozygous de novo 2.6 Mb deletion in chromosomal region 22q11.21. The cytogenetic analysis also revealed a 1.4 Mb homozygous deletion in chromosomal region Xp22.31 including the STS gene. This recurrent deletion is responsible for X-chromosome-linked ichthyosis. Accordingly, the two twins demonstrated dry and scaly skin. Some reports indicated that this deletion might also be associated with attention-deficit hyperactivity and autism spectrum disorder ([@bb0020]; [@bb0060]; [@bb0160]), but neither of the two twins reached the DSM-5 criteria for these comorbidities. Anatomical brain MRI data were unremarkable.

The clinical histories of the twins were highly similar. They were born by caesarean delivery after 36 weeks of gestation and have been educated together in similar conditions. They are still living with their parents. They displayed mild 22q11.2DS dysmorphic facial features without velopharyngeal insufficiency. They presented with neither immune deficiency nor hypocalcemia. Twin1 exhibited a common arterial trunk during the neonatal period that required a surgery without complication and Twin2 was asymptomatic. From a neurodevelopmental perspective, they presented with a mild delay concerning walking and speech and were described as 'turbulent' children without fulfilling DSM-5 criteria for attention-deficit hyperactivity disorder. They received speech, orthoptic, and psychomotor therapies during their childhood. They encountered learning problems at school, but both were capable of pursuing their training and graduated with a vocational baccalaureate. The extensive neuropsychological examination concludes to a borderline intellectual functioning with a similar profile in both twins. Basic shape perceptions seemed efficient while spatial perceptions were impaired. The twins also had consequent visuo-constructive disabilities associated with a moderate dysexecutive syndrome. Working memory abilities were equally accurate, but learning curves were reduced and long-term recall abilities impaired (for details, see [Table 1](#t0005){ref-type="table"}).Table 1Behavioural and cognitive profile of the twins suffering from 22q11.2DS (raw score).Table 1Twin 1Twin 2**Schizophrenic symptoms** PANSS - positive symptoms score208 PANSS - negative symptoms score2414 PANSS - general symptoms score3922 PANSS - total score8344**Gobal cognitive abilities** WAIS IV - verbal comprehension index7577 WAIS IV - perceptual reasoning index62 \*70 WAIS IV - processing speed index7783 WAIS IV - working memory index8481 WAIS IV -- full scale intellectual quotient68 \*[†](#tf0005){ref-type="table-fn"}72**Visuo-spatial functions** VOSP - screening test (total score)2020 VOSP - incomplete letters (total score)2019 BORB - foreshortened view task (total score)2420 Benton judgment of line orientation test (total score)14 \*12 \* Rey complex figure copy test (total score)19.5 \*25 \***Attentional and executive functions** D2 - concentration performance index135135 TMT - flexibility index (time)4943 TMT - flexibility index (errors)00 Stroop test - interference index (time)3624 Stroop test - interference index (errors)4 \*10 \* Brixton spatial anticipation test (errors)22 \*21 \***Memory** WAIS IV - digit span test (total score)2323 WMS III - spatial memory test (total score)1414 CVLT - learning (total score)42\*46 \* CVLT - long term recall (total score)89[^1][^2]

At the time of testing, the psychiatric presentation of each twin only differed regarding schizophrenic symptoms. Twin1 presented with schizophrenia according to DSM-5 criteria. He displayed delusions, suspiciousness, hostility, blunted affect, emotional withdrawal, lack of spontaneity, stereotyped thinking, active social avoidance, and anxiety. Twin2 presented with an isolated blunted affect without psychotic symptoms. Discordant clinical observations between both twins were confirmed by the PANSS scores (for details, see [Table 1](#t0005){ref-type="table"}). Neither has a history of antipsychotic treatment nor received drug during the testing period.

2.2. Experimental procedure {#s0020}
---------------------------

Two measures were used to assess emotional face processing.

### 2.2.1. TREF test {#s0025}

The TREF test ([@bb0105]) assesses the ability to recognize six basic emotions (joy, anger, sadness, fear, disgust, and contempt). Fifty-four emotional faces are presented for 10 s each with nine levels of intensity ranging from 20% to 100%. Participants have to choose orally the correct answer among the 6 written labels of basic emotions. No time limit for responding is applied. This test provides a global percentage of emotion recognition and a threshold of intensity at which emotions are correctly recognized. Detailed procedure and score computation are available in [@bb0105] and the supplementary file.

### 2.2.2. Facial expression perception (FEP) measurement {#s0030}

A fast periodic visual stimulation coupled with EEG was used to implicitly measure the detection of brief changes of facial expression (anger, disgust, fear, happiness and sadness) at different intensity levels (20%, 60%, 100%). This paradigm was adapted from previous studies ([@bb0170], [@bb0175]), and details of the procedure and data acquisition are available in the supplementary file. Briefly, neutral faces were presented at a base rate of 6 Hz and expressive faces were introduced at a lower rate of 1.2 Hz (i.e., every 5 stimuli). This frequency-tagging approach allows dissociating two brain responses: the first one elicited at 6 Hz and harmonics (i.e., integer multiples) reflects the general visual processing of the rapid stream of stimulation; the second one elicited at 1.2 Hz and harmonics precisely indexes the discrimination of facial expression from neutrality. Participants performed a non-periodic orthogonal task (i.e., unrelated to facial expression perception) asking them to detect shape-changes (i.e., to square) of a fixation circle continuously presented just below the eyes of the face stimuli.

2.3. Data processing and statistical analyses {#s0035}
---------------------------------------------

### 2.3.1. TREF data analysis {#s0040}

The global percentage of emotion recognition and the threshold of intensity of both patients were compared to 38 healthy controls (men without history of psychiatric or genetic disease, mean age ± standard error: 21.47 ± 1.84) (unpublished data) by using the Crawford and Howell\'s adapted *t*-test ([@bb0090]) (*p* \< .05, two-tailed). Normality of the sample was tested thanks to Shapiro-Wilk normality test (p \< .05).

### 2.3.2. FEP measurement data analyses {#s0045}

For the orthogonal behavioural task, percentage of correct detection occurring between 150 and 1000 ms was calculated to ensure that both twins paid full attention to the screen during stimulation. For EEG data, detailed preprocessing and analysis steps are described in the supplementary file. Briefly, EEG amplitude spectra were analysed in the frequency domain using fast Fourier transform. For both general visual and facial expression change responses, the signal amplitude was summed across harmonics, and noise amplitude was estimated from 20 surrounding frequency bins. Corrected amplitude of neural responses was quantified by subtracting mean noise from the signal amplitude. *Z*-scores were also computed to estimate the significance of the responses (signal minus mean noise divided by the standard deviation of the noise). To compare both responses between twins, the difference between their summed uncorrected amplitudes was calculated and Z-scores were computed. An exploratory analysis was conducted across 48 posterior electrodes since previous studies revealed a posterior topography for both brain responses measured with a similar design ([@bb0100]; [@bb0170]). The Z-score significance threshold was adjusted using Bonferroni correction for multiple comparisons between electrodes (Z \> 3.08, *p* \< .001, one-tailed, signal \> noise for the significance of each brain response; Z \> 3.28 or \< −3.28, p \< .001, two-tailed for the significance of the difference between twins).

According to previous studies, the expression-change response is not significant for low-intensity facial expressions in both healthy and 22q11.2DS participants ([@bb0170], [@bb0175]). Consequently, separate analyses were performed for the 20% expression intensity (referred to as low intensity condition), and for 60% and 100% combined (referred to as high intensity condition). Analysis of the general visual response was performed on the average across expression intensities. To increase signal-to-noise ratio, both responses were averaged across emotions.

3. Results {#s0050}
==========

3.1. TREF test {#s0055}
--------------

Data of the healthy control group follow a normal distribution (global recognition score: W = 0.97, *p* = .30; threshold of intensity: W = 0.96, *p* = .10). The TREF test indicated that both twins exhibited lower global recognition scores than controls (Controls: 72.47% ± 7.64; Twin1: 55.56%, t(27) = −2.17, *p* \< .05; Twin2: 48.15%, t(27) = −3.13, *p* \< .01) and higher thresholds of intensity at which emotions are recognized (Controls: 46.47% ± 7.78; Twin1: 66.67%, t(27) = 2.55, *p* \< .02; Twin2: 78.33%, t(27) = −4.02, p \< .001). Further details are provided in the supplementary file.

3.2. FEP measurement {#s0060}
--------------------

For the orthogonal behavioural task (i.e., shape-change detection of the fixation circle) performed during EEG recordings, results were 89.4% correct responses for Twin1 and 95.0% correct responses for Twin2. These results ensure that both paid full attention to the visual stimulation.

Similarly, the general visual response in EEG was significant over all 48 electrodes for both twins (Zs \> 3.08, ps \< 0.001). The direct comparison between twins for the general visual response reached significance for 40 electrodes. The response was larger for Twin 1 over 14 electrodes (Zs \< −4.15, ps \< 0.001), and the reverse pattern was found over another 26 electrodes (Zs \> 3.33, ps \< 0.001).

The expression-change brain response to low-intensity facial expressions did not reach significance for either twin (Zs \< 1.81, ps \> 0.04) and did not significantly differed between twins (Zs \< 2.00, ps \> 0.045). Importantly, the response to high-intensity facial expressions did not reach significance over any electrode for Twin1 (Zs \< 0.88, ps \> 0.19) while it reached significance over 11 electrodes for Twin2 (Zs \> 3.23, ps \< 0.001). Accordingly, the response to high-intensity facial expressions was lower for Twin1 than Twin2 over 8 electrodes (Zs \> 3.39, ps \< 0.001), in line with the significant expression-change response found only for Twin 2.

Details of the EEG results are provided in [Fig. 1](#f0005){ref-type="fig"} and in the supplementary file.Fig. 1A. 3D-topographical maps (posterior view) of summed corrected amplitudes for the general visual response (top) and for the facial expression specific response (bottom) at low and high intensities for Twin1 (with psychotic symptoms) and Twin2 (without psychotic symptoms). B. Localization of the electrodes for which the brain responses significantly differ between twins.Fig. 1

4. Discussion {#s0065}
=============

The present study aimed at better circumscribing the neurocognitive endophenotype of psychotic symptoms by considering confounding factors and using a twin study with an experimental paradigm that specifically measures facial emotion perception at the individual level. The results of this exploratory study support the association between psychotic symptoms and impaired facial expression perception.

As hypothesized, the classical behavioural task of face recognition (TREF test) failed to be clearly associated with psychotic symptoms in Twin1 in comparison with Twin2 since their scores were both impaired in comparison with the control sample. On the contrary, the FEP measurement showed that the twin suffering from psychotic symptoms (Twin1) did not detect facial expression changes while the other (Twin2) did, in line with previous evidence showing a relationship between positive symptoms of psychosis and such automatic perception of facial expression changes ([@bb0175]). Direct comparison between the twins confirmed that the EEG response to emotional faces was lower in Twin1 than Twin2.

It could be possible that this impairment represents one aspect of a broader difficulty to detect some pattern changes within visual stimuli irrespective of social content, as defined in the hypothesis of a coarser resolution of spatiotemporal information in 22q11.2DS ([@bb0255]). This interesting alternative interpretation could adequately apply to the present observation since facial expression changes were displayed briefly. Further studies are needed to explore this option. However, it is worth noting that the general visual response to the rapid stream of stimulation was significant in both participants indicating that stimulus luminance, contrast and size are perceived. The high accuracy for both twins in the orthogonal task also indicates that they perceived the target. This could lead to discard any interpretation in terms of reduced global visual sensitivity. Direct comparisons between the twins also revealed a distinct topographical pattern. Future studies should investigate whether this different topography between twins could also be associated with the presence of psychotic symptoms.

Either way, the difficulties of Twin1 in the FEP measurement were thus specific to the visual processing of a change of facial expression from a neutral face. There is therefore discordance between explicit emotion labelling tasks and implicit facial expression perception, suggesting that facial expression perception is closely related to psychotic symptoms whereas explicit emotion recognition is a more widespread phenotype in 22q11.2DS individuals irrespective of their psychotic status. In other words, the ability to explicitly attribute an emotion to expressive faces seems generally impaired in 22q11.2DS while only individuals with psychotic symptoms may additionally (and even primarily) suffer from difficulties in perceiving distinct facial expressions. Since the brain response to expressive faces measured in the present study is exempt from explicit processes, it appears to be a reliable potential endophenotype of psychotic symptoms ([@bb0175]). This marker could be appropriately used in future genetic studies as well as in clinical care strategies, in place of standard behavioural measures that provide only moderate specificity for psychotic symptoms. Admittedly, one limitation of the present study is the lack of longitudinal data. No assumption can be made on any causal relationship between facial expression perception and psychotic symptoms emergence. Another limitation would be that the mere comparison of twins can be considered as a fixed effect analysis (psychotic vs. non-psychotic) that hardly generalizes to the whole 22q11.2DS population. However, since the present findings are concordant with a previous study using the same approach without fixing the "psychotic symptoms" parameter ([@bb0175]), we remain confident about the generalizability of our observations.

Some reports have previously challenged the idea of a specific social cognitive dysfunction associated with the the occurrence of psychotic manifestations. Global cognitive decline and/or cognitive inflexibility were proposed as predictors of psychotic symptom onset in 22q11.2DS ([@bb0005]; [@bb0250]; [@bb0270]; [@bb0290]; [@bb0310]). There is much evidence across various clinical conditions (including 22q11.2DS) that global cognitive and/or executive capacity may partly explain the performance heterogeneity in social cognitive tasks ([@bb0220]; [@bb0315]). Nevertheless, global intellectual abilities, executive and general visuo-spatial functions presumably did not account for psychotic symptoms in our study since cognitive profiles are highly similar across twins. The present results are rather coherent with recent data that failed to find evidence for general cognitive ability decrement in correlation with psychotic symptoms in 22q11.2DS ([@bb0075]; [@bb0205]). They also support the recent view of a clear relationship between social cognitive impairment and psychotic symptoms ([@bb0005]; [@bb0015]; [@bb0145], [@bb0150]; [@bb0310]).

The etiology of the incomplete penetrance of psychosis in 22q11.2DS is a highly critical question. Regarding genetic explanations, several hypotheses have been raised, ranging from additional genomic mutation outside of the 22q region ([@bb0025]; [@bb0030]; [@bb0285]) to epigenetic factors ([@bb0085]; [@bb0260]; [@bb0265]), without forgetting the potential role of the other allele and especially COMT polymorphisms ([@bb0120], [@bb0125]; [@bb0130]; [@bb0190]; [@bb0275]) or intergenic noncoding RNA genes ([@bb0190]). A more integrative model suggests that psychotic symptoms may occur from genetic risk combined with negative life events, traumatic experiences, and/or attachment disorder ([@bb0040]). Although it cannot definitely rule out or validate these potential explanations, the present study might reasonably highlight some of them. The case of the two monozygotic twins discordant for psychotic symptoms also tends to discard the role of an additional genomic event and drives us to focus on epigenetic and transcriptomic investigations. This view was recently supported by a study that correlated long term mental disorder in 22q11DS with differential DNA methylation at birth ([@bb0265]). However, this hypothesis raises the issue of epigenome changes ([@bb0280]) in monozygotic twins who have grown up together. The only known environmental difference between the twins is a cardiac surgery. Nevertheless, previous data did not find a substantial link between congenital heart disease and further psychiatric symptom onset in 22q11.2DS ([@bb0320]). Further investigations are thus required.

In any case, the experimental design of the present study -- that is, the combination of a specific electrophysiological measure of a cognitive process and the selection of patients that leads to comparable environmental and genomic factors -- provides a unique opportunity to bring forward the discussion on the neurocognitive endophenotype of psychotic symptoms. The present data ideally should be confirmed by replication studies. In practice, the scarcity of 22q11.2DS restricts the possibility of studying a large cohort of monozygotic twins with heterogeneous clinical presentation of psychotic symptoms.
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Supplementary materialImage 1

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.nicl.2019.101987>.

[^1]: PANSS = Positive And Negative Symptoms Scale ([@bb0155]); WAIS IV = Wechsler Adult Intelligence Scale fourth edition ([@bb0305]); VOSP = Visual Object and Space Perception Battery ([@bb0295]); Birmingham Object Recognition battery ([@bb0240]); Benton judgment of line orientation test ([@bb0035]); Rey complex figure copy test ([@bb0235]); D2 ([@bb0055]); TMT = Trail Making Test ([@bb0110]); Stroop test ([@bb0110]); Brixton spatial anticipation test ([@bb0110]); WMS III = Wechsler memory Scale third edition ([@bb0300]); CVLT = California Verbal Learning Test ([@bb0095]). Asterisks (\*) represent scores which were two standard deviations or more from the normative sample mean.

[^2]: The full scale intellectual quotient must be carefully interpreted since differences between index scores are statistically significant (the perceptual reasoning index is lower than the three others indexes).
